Jamie Brett

Jamie Brett discusses the similarities and differences between ESR1 mutations and fusions and why they are grouped together.

Jamie Brett, resident in internal medicine at Massachusetts General Hospital, discusses the effectiveness of CDK4/6 for patients with hormone receptor-positive metastatic breast cancer (MBC) with ESR1 mutations and fusions.